Skip to main content
main-content

The independent medical news service

13-12-2016 | Alzheimer's disease | News | Article

Gender and ethnicity affect protective role of statins against AD

The potential reduction in Alzheimer’s disease risk afforded by high use of statins varies by statin type, gender, and ethnicity, report researchers.

13-12-2016 | Parkinson's disease | News | Article

Biochemical test shows promise for diagnosing Parkinson’s disease

Researchers have developed a biochemical test for diagnosing Parkinson’s disease using technology that detects misfolded α-synuclein oligomers in cerebrospinal fluid.

08-12-2016 | Multiple sclerosis | News | Article

Newborn vitamin D status linked to future MS risk

Babies born with low levels of vitamin D may be at increased risk for multiple sclerosis in later life, suggests research.

07-12-2016 | Neurodegeneration | News | Article

‘New dawn’ for spinal muscular atrophy treatment

Nusinersen has shown promise as a treatment for infantile-onset spinal muscular atrophy, improving muscle function and nerve activity, show phase II study findings published in The Lancet.

05-12-2016 | Alzheimer's disease | News | Article

Occupational therapy fails to slow functional decline in Alzheimer’s disease

The addition of 2 years of in-home occupational therapy to collaborative care does not provide functional benefits for patients with Alzheimer’s disease.

01-12-2016 | Alzheimer's disease | News | Article

Amyloid beta present in the hearts of patients with Alzheimer’s disease

Researchers have identified intramyocardial amyloid beta aggregates and changes in cardiac function among patients with Alzheimer’s disease.

01-12-2016 | Epilepsy | News | Article

Support for lacosamide as a monotherapy in newly diagnosed epilepsy

Lacosamide could be suitable as a monotherapy for adults with newly diagnosed epilepsy, say researchers.

30-11-2016 | Alzheimer's disease | News | Article

US dementia decline reported

The prevalence of dementia in the USA has decreased between 2000 and 2012, and increasing educational attainment appears to be one of the contributing factors.

23-11-2016 | Parkinson's disease | News | Article

Biomarker combination predicts early Parkinson’s cognitive impairment risk

Adding cerebrospinal fluid assessment and dopamine transporter imaging data to age and clinical assessment improves cognitive impairment prediction in newly diagnosed patients with Parkinson’s disease, study findings indicate.

17-11-2016 | Alzheimer's disease | News | Article

Add-on anti-tau aggregation therapy fails to slow AD progression

Phase III trial results suggest there is no benefit to adding tau-aggregation inhibitor therapy to standard treatment in patients with mild to moderate Alzheimer’s disease.

16-11-2016 | Neurology | News | Article

Hormonal treatment with vigabatrin beats infantile spasms faster

Combining hormonal treatment and vigabatrin is significantly more effective at stopping infantile spasms than hormonal treatment alone, ICISS study findings indicate.

15-11-2016 | Neurology | News | Article

Brain implant allows paralyzed ALS patient to communicate

Researchers have developed a brain implant that has enabled a paralyzed, locked-in patient with late-stage amyotropic lateral sclerosis to communicate through a speech computer using her mind.

09-11-2016 | Stroke | News | Article

Endovascular treatment benefits some acute stroke patients with large ischemic core

Irreversibly damaged tissue should not rule out endovascular treatment for acute ischemic stroke for all patients, case–control study findings in JAMA Neurology suggest.

04-11-2016 | Neurology | News | Article

Phase I trial links fatty acid amide hydrolase inhibitor to severe neurologic disorder

Researchers warn of neurologic adverse effects with BIA 10-2474, a reversible fatty acid amide hydrolase inhibitor with analgesic and anti-inflammatory potential.

03-11-2016 | Alzheimer's disease | News | Article

Hippocampal volume predicts dementia with Lewy bodies likelihood

Preserved hippocampal volume could distinguish which patients with mild cognitive impairment are likely to develop dementia with Lewy bodies rather than Alzheimer’s disease, researchers report.

02-11-2016 | Diabetes | News | Article

Epilepsy risk may be heightened in type 1 diabetes patients

A population-based study reveals a threefold increased rate of epilepsy diagnosis among patients with type 1 diabetes, after accounting for social deprivation, cerebral palsy, head injury, and learning disability.

01-11-2016 | Neurology | News | Article

Parent-focused early autism intervention has long-lasting effect

Researchers report sustained benefits almost 6 years after an early intervention for autism that focuses on improving the way parents interact and communicate with their child.

28-10-2016 | Neurology | News | Article

Pediatric migraine drug effectiveness trial falls short

Current medications prescribed for the treatment of migraine in children and adolescents appear to be no more effective than placebo, findings from the CHAMP study indicate.

25-10-2016 | Parkinson's disease | News | Article

Inhaled levodopa may relieve ‘off’ motor symptoms

CVT-301, an inhaled powdered form of levodopa, may help relieve “off” motor fluctuations that occur between doses of standard oral levodopa, phase II findings indicate.

24-10-2016 | Alzheimer's disease | News | Article

Transient blood pressure drop poses dementia risk

Orthostatic hypotension has been linked to an increased long-term risk of dementia in a study published in PLoS Medicine.

Image Credits